These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22871397)

  • 21. Secure anonymous mutual authentication for star two-tier wireless body area networks.
    Ibrahim MH; Kumari S; Das AK; Wazid M; Odelu V
    Comput Methods Programs Biomed; 2016 Oct; 135():37-50. PubMed ID: 27586478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EXpectation Propagation LOgistic REgRession on permissioned blockCHAIN (ExplorerChain): decentralized online healthcare/genomics predictive model learning.
    Kuo TT; Gabriel RA; Cidambi KR; Ohno-Machado L
    J Am Med Inform Assoc; 2020 May; 27(5):747-756. PubMed ID: 32364235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of industry funded post-marketing studies to drug safety: survey of notifications submitted to regulatory agencies.
    Spelsberg A; Prugger C; Doshi P; Ostrowski K; Witte T; Hüsgen D; Keil U;
    BMJ; 2017 Feb; 356():j337. PubMed ID: 28174182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient Perspectives on Health Data Privacy and Implications for Adverse Drug Event Documentation and Communication: Qualitative Study.
    Small SS; Hohl CM; Balka E
    J Med Internet Res; 2021 Jan; 23(1):e21452. PubMed ID: 33470936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric post-marketing safety systems in North America: assessment of the current status.
    McMahon AW; Wharton GT; Bonnel R; DeCelle M; Swank K; Testoni D; Cope JU; Smith PB; Wu E; Murphy MD
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):785-92. PubMed ID: 26098297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secure and Efficient Regression Analysis Using a Hybrid Cryptographic Framework: Development and Evaluation.
    Sadat MN; Jiang X; Aziz MMA; Wang S; Mohammed N
    JMIR Med Inform; 2018 Mar; 6(1):e14. PubMed ID: 29506966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A flexible approach to distributed data anonymization.
    Kohlmayer F; Prasser F; Eckert C; Kuhn KA
    J Biomed Inform; 2014 Aug; 50():62-76. PubMed ID: 24333850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some methods for blindfolded record linkage.
    Churches T; Christen P
    BMC Med Inform Decis Mak; 2004 Jun; 4():9. PubMed ID: 15222890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Privacy-preserving data sharing infrastructures for medical research: systematization and comparison.
    Wirth FN; Meurers T; Johns M; Prasser F
    BMC Med Inform Decis Mak; 2021 Aug; 21(1):242. PubMed ID: 34384406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicenter random forest model for effective prognosis prediction in collaborative clinical research network.
    Li J; Tian Y; Zhu Y; Zhou T; Li J; Ding K; Li J
    Artif Intell Med; 2020 Mar; 103():101814. PubMed ID: 32143809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can Disproportionality Analysis of Post-marketing Case Reports be Used for Comparison of Drug Safety Profiles?
    Michel C; Scosyrev E; Petrin M; Schmouder R
    Clin Drug Investig; 2017 May; 37(5):415-422. PubMed ID: 28224371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Secure Multi-Party Computation to Protect Privacy on a Permissioned Blockchain.
    Zhou J; Feng Y; Wang Z; Guo D
    Sensors (Basel); 2021 Feb; 21(4):. PubMed ID: 33672175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secure Authentication Protocol for Wireless Sensor Networks in Vehicular Communications.
    Yu S; Lee J; Lee K; Park K; Park Y
    Sensors (Basel); 2018 Sep; 18(10):. PubMed ID: 30248898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A privacy-preserving distributed filtering framework for NLP artifacts.
    Sadat MN; Aziz MMA; Mohammed N; Pakhomov S; Liu H; Jiang X
    BMC Med Inform Decis Mak; 2019 Sep; 19(1):183. PubMed ID: 31493797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative performance of two quantitative safety signalling methods: implications for use in a pharmacovigilance department.
    Almenoff JS; LaCroix KK; Yuen NA; Fram D; DuMouchel W
    Drug Saf; 2006; 29(10):875-87. PubMed ID: 16970511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Social Media Listening for Routine Post-Marketing Safety Surveillance.
    Powell GE; Seifert HA; Reblin T; Burstein PJ; Blowers J; Menius JA; Painter JL; Thomas M; Pierce CE; Rodriguez HW; Brownstein JS; Freifeld CC; Bell HG; Dasgupta N
    Drug Saf; 2016 May; 39(5):443-54. PubMed ID: 26798054
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Establishment of the MID-NET
    Yamaguchi M; Inomata S; Harada S; Matsuzaki Y; Kawaguchi M; Ujibe M; Kishiba M; Fujimura Y; Kimura M; Murata K; Nakashima N; Nakayama M; Ohe K; Orii T; Sueoka E; Suzuki T; Yokoi H; Takahashi F; Uyama Y
    Pharmacoepidemiol Drug Saf; 2019 Oct; 28(10):1395-1404. PubMed ID: 31464008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Mutual Authentication Framework for Wireless Medical Sensor Networks.
    Srinivas J; Mishra D; Mukhopadhyay S
    J Med Syst; 2017 May; 41(5):80. PubMed ID: 28364358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uptake of new drugs in the early post-approval period in the Mini-Sentinel distributed database.
    Mott K; Graham DJ; Toh S; Gagne JJ; Levenson M; Ma Y; Reichman ME
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1023-32. PubMed ID: 27146123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A method for systematic discovery of adverse drug events from clinical notes.
    Wang G; Jung K; Winnenburg R; Shah NH
    J Am Med Inform Assoc; 2015 Nov; 22(6):1196-204. PubMed ID: 26232442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.